Literature DB >> 10358336

Histopathology of vanishing bile duct diseases.

.   

Abstract

This manuscript reviews and summarizes the histopathology of the liver in the various "vanishing bile duct diseases". These represent conditions associated with progressive disappearance of intrahepatic bile duct branches. Congenital diseases of this nature comprise so-called extrahepatic bile duct atresia and paucity of interlobular bile ducts (syndromic and non-syndromic). In the adult, vanishig bile duct diseases are represented amongst others, by primary biliary cirrhosis, primary sclerosing cholangitis, idiopathic adulthood ductopenia, liver allograft rejection, graft-versus-host disease and drug-induced and toxic cholangitis.

Entities:  

Year:  1998        PMID： 10358336

Source DB:  PubMed          Journal:  Adv Clin Path        ISSN： 1125-5552


  9 in total

Review 1.  Estrogens and the pathophysiology of the biliary tree.

Authors:  Domenico Alvaro; Maria Grazia Mancino; Paolo Onori; Antonio Franchitto; Gianfranco Alpini; Heather Francis; Shannon Glaser; Eugenio Gaudio
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 2.  Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology.

Authors:  Antonio Franchitto; Paolo Onori; Anastasia Renzi; Guido Carpino; Romina Mancinelli; Domenico Alvaro; Eugenio Gaudio
Journal:  Ann Transl Med       Date:  2013-10

Review 3.  Recent advances in the morphological and functional heterogeneity of the biliary epithelium.

Authors:  Yuyan Han; Shannon Glaser; Fanyin Meng; Heather Francis; Marco Marzioni; Kelly McDaniel; Domenico Alvaro; Julie Venter; Guido Carpino; Paolo Onori; Eugenio Gaudio; Gianfranco Alpini; Antonio Franchitto
Journal:  Exp Biol Med (Maywood)       Date:  2013-05

4.  Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders.

Authors:  S Engler; C Elsing; C Flechtenmacher; L Theilmann; W Stremmel; A Stiehl
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 5.  Women and primary biliary cirrhosis.

Authors:  Ying Sun; Krista Haapanen; Baosen Li; Weici Zhang; Judy Van de Water; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

6.  Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors.

Authors:  James H Lewis; Hans Gelderblom; Michiel van de Sande; Silvia Stacchiotti; John H Healey; William D Tap; Andrew J Wagner; Antonio Lopez Pousa; Mihaela Druta; Chia-Chi Lin; Hideo A Baba; Youngsook Choi; Qiang Wang; Dale E Shuster; Sebastian Bauer
Journal:  Oncologist       Date:  2020-12-24

Review 7.  Management of drug-induced liver disease.

Authors:  G Marino; H J Zimmerman; J H Lewis
Journal:  Curr Gastroenterol Rep       Date:  2001-02

Review 8.  Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver.

Authors:  Luis E Soria-Jasso; Raquel Cariño-Cortés; Víctor Manuel Muñoz-Pérez; Elizabeth Pérez-Hernández; Nury Pérez-Hernández; Eduardo Fernández-Martínez
Journal:  Int J Mol Sci       Date:  2019-09-22       Impact factor: 5.923

9.  Paucity of intrahepatic bile ducts in neonates: the first case series from iran.

Authors:  Zahmatkeshan Mozhgan; Geramizadeh Bita; Haghighat Mahmood; Enteshari Hajar
Journal:  Iran J Pediatr       Date:  2013-02       Impact factor: 0.364
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.